Changeflow GovPing Healthcare FDA Class II Device Recall: GEM Premier 5000 PAK
Urgent Enforcement Removed Final

FDA Class II Device Recall: GEM Premier 5000 PAK

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has initiated a Class II device recall for Instrumentation Laboratory's GEM Premier 5000 PAK (Part No. 00055360011) due to Process Control Solution Not Detected (PCSND) errors. The recall affects worldwide distribution, including the US.

What changed

The FDA has classified a recall of the GEM Premier 5000 PAK (Part No. 00055360011) as Class II, identified by recall number Z-1527-2026. This action stems from confirmed customer complaints indicating an increased incidence of Process Control Solution Not Detected (PCSND) errors during the warm-up phase of the GEM PAK cartridges. These errors can lead to GEM PAK ejection, necessitating the insertion of a new cartridge.

Healthcare providers using the GEM Premier 5000 system should be aware of this recall and potential issues with the GEM PAK cartridges. While the recall is ongoing and distribution is worldwide, including the US, specific actions required by users are not detailed in this notice. Compliance officers should review internal procedures for managing device errors and consider contacting the manufacturer for guidance on affected units and potential replacements or remediation steps.

What to do next

  1. Review internal procedures for managing GEM Premier 5000 PAK errors.
  2. Contact Instrumentation Laboratory for guidance on affected units and remediation.

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1527-2026 · 20260318 · Ongoing

Product

GEM Premier 5000 PAK; Part No. 00055360011.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1527-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Device Recalls
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Product Safety Healthcare

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.